Impact of Fli-1 transcription factor on autoantibody and lupus nephritis in NZM2410 micecei_4245 362..371

Clinical and Experimental Immunology

Volumn 162, Issue 2, 2010, Pages 362-371

  Mathenia, J ^a,b   Reyes Cortes, E ^a   Williams, S ^b   Ruiz, I Molano ^c   Watson, D K ^d   Gilkeson, G S ^a,b   Zhang, X K ^a,b  

^a Division of Rheumatology and Immunology ^*  (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

?Nephritis; Animal model; Autoantibody; Fli 1 transcription factor; Lupus

Indexed keywords

AUTOANTIBODY; DOUBLE STRANDED DNA ANTIBODY; EARLY GROWTH RESPONSE FACTOR 1; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; TRANSCRIPTION FACTOR FLI 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IMMUNOPATHOGENESIS; KIDNEY PARENCHYMA; KNOCKOUT MOUSE; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; STRAIN DIFFERENCE; SURVIVAL; WILD TYPE;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIBODY FORMATION; AUTOANTIBODIES; B-LYMPHOCYTES; CELL COUNT; EARLY GROWTH RESPONSE PROTEIN 1; FEMALE; GENE EXPRESSION; IMMUNOGLOBULIN G; KIDNEY; LUPUS NEPHRITIS; MALE; MICE; MICE, INBRED MRL LPR; MICE, KNOCKOUT; PROTEINURIA; PROTO-ONCOGENE PROTEIN C-FLI-1; SPLEEN; SURVIVAL ANALYSIS; T-LYMPHOCYTES;

EID: 78649255039     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04245.x     Document Type: Article

References (36)

1. Watson DK, Smyth FE, Thompson DM et al. The ERGB/Fli-1 gene: isolation and characterization of a new member of the family of human ETS transcription factors. Cell Growth Differ 1992; 3:705- 13.
2. Ben-David Y, Giddens EB, Letwin K, Bernstein A. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev 1991; 5:908-18.
3. Seth A, Ascione R, Fisher RS, Mavrothalassitis GJ, Bhat NK, Papas TS. The ets gene family. Cell Growth Differ 1992; 3:327-34.
4. Karim FD, Urness LD, Thummel CS et al. The ETS-domain: a new DNA-binding motif that recognizes a purine-rich core DNA sequence. Gene Dev 1990; 4:1451-3.
5. Papas TS, Bhat NK, Spyropoulos DD et al. Functional relationships among ETS gene family members. Leukemia 1997; 11:557-66.
6. Athanasiou M,Clausen PA,Mavrothalassitis GJ, Zhang XK,Watson DK, Blair DG. Increased expression of ETS-related transcriptional factor FLI-1/ERGB correlates with and can induce the megakaryocytic phenotype. Cell Growth Differ 1996; 7:1525-34.
7. Lemarchandel V, Ghysdael J, Mignotte V, Rahuel C, Romeo PH. GATA and Ets cis-acting sequences mediate megakaryocytespecific expression. Mol Cell Biol 1993; 13:668-76.
8. Wang X, Crispino JD, Letting DL, Nakazawa M, Poncz M, Blobel GA. Control of megakaryocyte-specific gene expression by GATA-1 and FOG-1: role of Ets transcription factors. EMBO J 2002; 21:225-34.
9. Szalai G, LaRue AC, Watson DK. Molecular mechanisms of megakaryopoiesis. Cell Mol Life Sci 2006; 63:2460-76.
10. Zhang XK,Moussa O, LaRue A et al. The transcription factor Fli-1 modulates marginal zone and follicular B cell development. J Immunol 2008; 181:1644-54.
11. Spyropoulos DD, Pharr PN, Lavenburg KR et al. Hemorrhage, impaired hemotopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor.Mol Cell Biol 2000; 20:5643-52.
12. Hart A, Melet F, Grossfeld P et al. Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity 2000; 13:167-77.
13. Mills JA. Systemic lupus erythematosus. N Engl J Med 1994; 330:1871-9.
14. Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol 2003; 56:481-90.
15. Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Parks CG, Gilkeson GS. Hormonal, environmental, and infectious disease risk factors for the development of systemic lupus erythematosus. Arthritis Rheum 1998; 41:1714-24.
16. Georgiou P, Maroulakou IG, Green JE et al. Expression of ets family of genes in systemic lupus erythematosus and Sjogren's syndrome. Int J Oncol 1996; 9:9-18.
17. Zhang L, Eddy A, Teng YT et al. An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes. Mol Cell Biol 1995; 15:6961-70.
18. Zhang XK, Gallant S, Molano I et al. Decreased expression of the ets family transcription factor fli-1 markedly prolongs survival and significantly reduces renal disease in MRL/lpr mice. J Immunol 2004; 173:6481-9.
19. Theofilopoulos AN, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol 1985; 37:269-390.
20. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356:314-17.
21. Watson ML, Rao JK, Gilkeson GS et al. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J Exp Med 1992; 176:1645- 56.
22. Davidson WF, Dumont FJ, Bedigian HG, Fowlkes BJ, Morse HC 3rd. Phenotypic, functional, and molecular genetic comparisons of the abnormal lymphoid cells of C3H-lpr/lpr and C3H-gld/gld mice. J Immunol 1986; 136.
23. Rudofsky UH, Evans BD, Balaban SL, Mottironi VD, Gabrielsen AE. Differences in expression of lupus nephritis in New Zealand mixed H-2Z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization. Lab Invest 1993; 68:419-26.
24. Morel L, Yu Y, Blenman KR, Caldwell RA, Wakeland EK. Production of congenic mouse strains carrying genomic intervals containing SLE-susceptibility genes derived from the SLE-prone NZM2410 strain. Mamm Genome 1996; 7:335-9.
25. Watanabe H, Carnier G, Circolo A et al. Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B. J Immunol 2000; 164:786-94.
26. Sekine H, Reilly CM,Molano I et al. Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL.lpr mice. J Immunol 2001; 166:6444-51.
27. Watson DK, Robinson L, Hodge DR, Kola I, Papas TS, Seth A. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements. Oncogene 1997; 14:213- 21.
28. Rupprecht HD, Hoffer G, de Heer E, Sterzel RB, Faller G, Schoecklmann HO. Expression of the transcriptional regulator Egr-1 in experimental glomerulonephritis: requirement for mesangial cell proliferation. Kidney Int 1997; 51:694-702.
29. Carl M, Akagi Y, Weidner S, Isaka Y, Imai E, Rupprecht HD. Specific inhibition of Erg-1 prevents mesangial cell hypercellularity in experimental nephritis. Kidney Int 2003; 63:1302-12.
30. Bradshaw S, Zheng W-J, Tsoib L-C, Gilkeson G, Zhang XK. A role for Fli-1 in B cell proliferation: implications for SLE pathogenesis. Clin Immunol 2008; 129:19-30.
31. Li Y, Li H,Weigert M. Autoreactive B cells in the marginal zone that expresses dual receptors. J Exp Med 2002; 195:181-8.
32. Wellmann U, Wergner A, Winkler TH. Altered selection processes of B lymphocytes in autoimmune NZB/W mice, despite intact central tolerance against DNA. Eur J Immunol 2001; 31:2800-10.
33. Grimaldi CM, Michael DJ, Diamond B. Expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J Immunol 2001; 167:1886-90.
34. Xie C, Zhou XJ, Liu X, Mohan C. Enhanced susceptibility to endorgan disease in the lupus-facilitating NZW mouse strain. Arthritis Rheum 2003; 48:1080-92.
35. Molano I, Mathenia J, Ruiz P, Gilkeson GS, Zhang XK. Decreased expression of Fli-1 in bone marrow-derived haematopoietic cells significantly affects disease development in Murphy Roths Large/lymphoproliferation (MRL/lpr) mice. Clin Exp Immunol 2010; 180:275-82.
36. Masuya M, Moussa O, Abe T et al. Dysregulation of granulocyte, erythrocyte, and NK cell lineage in Fli-1 gene-targeted mice. Blood 2005; 105:95-102.